Pervasive gaps in Amazonian ecological research

Biodiversity loss is one of the main challenges of our time, and attempts to address it require a clear understanding of how ecological communities respond to environmental change across time and space. While the increasing availability of global databases on ecological communities has advanced our knowledge of biodiversity sensitivity to environmental changes, vast areas of the tropics remain understudied. In the American tropics, Amazonia stands out as the world's most diverse rainforest and the primary source of Neotropical biodiversity, but it remains among the least known forests in America and is often underrepresented in biodiversity databases. To worsen this situation, human-induced modifications may eliminate pieces of the Amazon's biodiversity puzzle before we can use them to understand how ecological communities are responding. To increase generalization and applicability of biodiversity knowledge, it is thus crucial to reduce biases in ecological research, particularly in regions projected to face the most pronounced environmental changes. We integrate ecological community metadata of 7,694 sampling sites for multiple organism groups in a machine learning model framework to map the research probability across the Brazilian Amazonia, while identifying the region's vulnerability to environmental change. 15%–18% of the most neglected areas in ecological research are expected to experience severe climate or land use changes by 2050. This means that unless we take immediate action, we will not be able to establish their current status, much less monitor how it is changing and what is being lost

Nanostructured Lipid Carriers As A Strategy To Improve The In Vitro Schistosomiasis Activity Of Praziquantel

Praziquantel (PZQ) is a pyrazinoisoquinoline anthelmintic that was discovered in 1972 by Bayer Germany. Currently, due to its efficacy, PZQ is the drug of choice against all species of Schistosoma. Although widely used, PZQ exhibits low and erratic bioavailability because of its poor water solubility. Nanostructured lipid carriers (NLC), second-generation solid lipid nanoparticles, were developed in the 1990s to improve the bioavailability of poorly water soluble drugs. The aim of this study was to investigate nanostructured lipid carriers as a strategy to improve the efficacy of PZQ in S. mansoni treatment. We prepared NLC2 and NLC4 by adding seventy percent glycerol monostearate (GMS) as the solid lipid, 30% oleic acid (OA) as the liquid lipid and two surfactant systems containing either soybean phosphatidylcholine/poloxamer (PC/P-407) or phosphatidylcholine/Tween 60 (PC/T60), respectively. The carriers were characterized by nuclear magnetic resonance, differential scanning calorimetry, thermogravimetric analysis and Fourier transform-infrared spectroscopy. The safety profile was evaluated using red cell hemolysis and in vitro cytotoxicity assays. The results showed that the encapsulation of PZQ in NLC2 or NLC4 improved the safety profile of the drug. Treatment efficacy was evaluated on the S. mansoni BH strain. PZQ-NLC2 and PZQ-NLC4 demonstrated an improved efficacy in comparison with free PZQ. The results showed that the intestinal transport of free PZQ and PZQ-NLC2 was similar. However, we observed that the concentration of PZQ absorbed was smaller when PZQ was loaded in NLC4. The difference between the amounts of absorbed PZQ could indicate that the presence of T60 in the nanoparticles (NLC4) increased the rigid lipid matrix, prolonging release of the drug. Both systems showed considerable in vitro activity against S. mansoni, suggesting that these systems may be a promising platform for the administration of PZQ for treating schistosomiasis.151761772Barsoum, R.S., Esmat, G., El-Baz, T., (2013) Journal of Advanced Research, 4, p. 433De Oliveira, R.N., Rehder, V.L.G., Santos Oliveira, A.S., Júnior, Í.M., De Carvalho, J.E., De Ruiz, A.L.T.G., De Lourdes Sierpe Jeraldo, V., Allegretti, S.M., (2012) Experimental Parasitology, 132, p. 135Allegretti, S.M., Oliveira, C.N.F., Oliveira, R.N., Frezza, T.F., Rehder, V.L.G., (2012), 27. , www.intechopen.com/books/schistosomiasisBygott, J.M., Chiodini, P.L., (2009) Acta Tropica, 111, p. 95Zhang, S.-M., Coultas, K.A., (2013) International Journal for Parasitology: Drugs and Drug Resistance, 3, p. 28Gryseels, B., Polman, K., Clerinx, J., Kestens, L., (2006) The Lancet, 368, p. 1106Doenhoff, M.J., Cioli, D., Utzinger, J., (2008) Curr. Opin. Infect. Dis., 1, p. 659Stelma, F.F., Talla, I., Sow, S., Kongs, A., Niang, M., Polman, K., Deelder, A.M., Gryseels, B., (1995) Am. J. Trop. Med. Hyg., 53, p. 167Mourao, S.C., Costa, P.I., Salgado, H.R., Gremiao, M.P., (2005) Int. J. Pharm., 295, p. 157Frezza, T.F., Madi, R.R., Banin, T.M., Pinto, M.C., Souza, A.L.R., Gremião, M.P.D., Allegretti, S.M., (2007) Journal of Basic and Applied Pharmaceutical Sciences, 28, p. 209Yang, L., Geng, Y., Li, H., Zhang, Y., You, J., Chang, Y., (2009) Pharmazie, 64, p. 86Souza, A., Andreani, T., Nunes, F., Cassimiro, D., Almeida, A., Ribeiro, C., Sarmento, V., Souto, E., (2012) J. Therm. Anal. Calorim., 108, p. 353Almeida, A., Souza, A., Cassimiro, D., Gremião, M., Ribeiro, C., Crespi, M., (2012) J. Therm. Anal. Calorim., 108, p. 333Souza, A.L.R., Kiill, C.P., Santos, F.K., Luz, G.M., Silva, H.R., Chorilli, M., Gremião, M.P.D., (2012) Current Nanoscience, 8, p. 512Santos, F.K., Oyafuso, M.H., Kiill, C.P., Gremiao, M.P.D., Chorilli, M., (2013) Current Nanoscience, 9, p. 159Cinto, P., Souza, A., Lima, A., Chaud, M., Gremião, M., (2009) Chromatographia, 69, p. 213Frezza, T.F., Gremião, M.P.D., Zanotti-magalhães, E.M., Magalhães, L.A., Souza, A.L.R., Allegretti, S.M., (2013) Acta TropicaCampos, F.D.S., Cassimiro, D.L., Crespi, M.S., Almeida, A.E., Gremião, M.P.D., (2013) Brazilian Journal of Pharmaceutical Sciences, 49, p. 75Müller, R.H., Petersen, R.D., Hommoss, A., Pardeike, J., (2007) Advanced Drug Delivery Reviews, 59, p. 522Han, F., Li, S., Yin, R., Liu, H., Xu, L., (2008) Colloids Surf., A: Physicochemical and Engineering Aspects, 315, p. 210Martins, S., Silva, A.C., Ferreira, D.C., Souto, E.B., (2009) Journal Biomedical Nanotechnology, 5, p. 76Silva, A.C., Santos, D., Ferreira, D.C., Souto, E.B., (2009) Pharmazie, 64, p. 177Jumaa, M., Kleinebudde, P., Müller, B.W., (1999) Pharmaceutica Acta Helvetiae, 73, p. 293Huang, Z.R., Hua, S.C., Yang, Y.L., Fang, J.Y., (2008) Acta Pharmacol. Sin., 29, p. 1094Olivier, L., Stirewalt, M.A., (1952) The Journal of Parasitology, 38, p. 19Smithers, S.R., Terry, R.J., (1965) Parasitology, 55, p. 695Xiao, S.H., Keiser, J., Chollet, J., Utzinger, J., Dong, Y., Endriss, Y., Vennerstrom, J.L., Tanner, M., (2007) Antimicrob. Agents Chemother., 51, p. 1440Cassimiro, D.L., Ferreira, L.M.B., Capela, J.M.V., Crespi, M.S., Ribeiro, C.A., (2013) Journal Of Pharmaceutical and Biomedical Analysis, 73, p. 24Garnero, C., Zoppi, A., Genovese, D., Longhi, M., (2010) Carbohydrate Research, 345, p. 2550Bottom, R., (2008) Thermogravimetric Analysis, Principles and Applications of Thermal Analysis, p. 87. , Blackwell Publishing LtdJores, K., Mehnert, W., Mader, K., (2003) Pharm. Res., 20, p. 1274Ali, H., El-Sayed, K., Sylvester, P.W., Nazzal, S., (2010) Colloids Surf. B Biointerfaces, 77, p. 286Pople, P.V., Singh, K.K., (2011) Eur. J. Pharm. Biopharm., 79, p. 82De Jesus, M.B., Pinto, L.M.A., Fraceto, L.F., Takahata, L.A.Y., Jaime, P.E.C., (2006) J. Pharm. Biomed. Anal., 41, p. 1428Hi, E.-S., Aa, A.-B., (1998) Analytical Profiles of Drug Substances and Excipients, 25, p. 463Schepmann, D., Blaschke, G., (2001) J. Pharm. Biomed. Anal., 26, p. 791Malheiros, S.V.P., Meirelles, N.C., De Paula, E., (2000) Biophys. Chem., 83, p. 89Raina, N., Goyal, A.K., Pillai, C.R., Rath, G., (2013) Indian Journal of Pharmaceutical Education and Research, 47, p. 123Abbasalipourkabir, R., Salehzadeh, A., Abdullah, R., (2011) Biotechnology, 10, p. 528Chiann, C., Gonçalves, J.E., Gai, M.N.M.N., Storpirtis, S.S., (2009) Biofarmacotécnica, 1, p. 352. , Guanabara Koogan, São PauloBaldrick, P., (2000) Regulatory Toxicology and Pharmacology, 32, p. 210Custodio, J.M., Wu, C.Y., Benet, L.Z., (2008) Advanced Drug Delivery Reviews, 60, p. 717Disch, J., Katz, N., Pereira E Silva, Y., De Gouvea Viana, L., Andrade, M.O., Rabello, A., (2002) Acta Trop, 81, p. 133Cioli, D., Pica-Mattoccia, L., (2003) Parasitol. Res., 90, p. 22Oliveira, C.N.F.D., Oliveira, R.N.D., Frezza, T.F., Rehder, V.L.C.G., Allegretti, S.M., (2013) Tegument of Schistosoma Mansoni as A Therapeutic Target, Parasitic Diseases-SchistosomiasisVan Hellemond, J.J., Retra, K., Brouwers, J.F., Van Balkom, B.W., Yazdanbakhsh, M., Shoemaker, C.B., Tielens, A.G., (2006) Int. J. Parasitol., 36, p. 691Barth, L.R., Fernandes, A.P., Rodrigues, V., (1996) Rev. Inst. Med. Trop. Sao Paulo, 38, p. 423Wilson, T.H., Wiseman, G., (1954) J. Physiol., 123, p. 116Balimane, P.V., Chong, S., Morrison, R.A., (2000) J. Pharmacol. Toxicol. Methods, 44, p. 30